Titan Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Cap	6	3	6	12	10	23
Market Cap Growth	20.24%	-53.77%	-44.95%	15.82%	-56.95%	115.44%
Enterprise Value	3.33	0.15	0.19	8.84	4.26	18.41
Last Close Price	4.61	3.26	8.25	15.60	20.40	65.80
PE Ratio	-	-0.62	-1.11	-1.03	-1.13	-1.68
PB Ratio	2.20	1.22	0.97	8.59	1.97	6.65
P/TBV Ratio	1.60	1.20	0.93	7.69	1.93	3.51
P/FCF Ratio	-	-0.77	-0.91	-1.43	-1.28	-1.32
P/OCF Ratio	-	-0.77	-0.91	-1.43	-1.28	-1.37
EV/EBITDA Ratio	-	30.08	1.68	45.11	19.29	63.04
EV/FCF Ratio	-	-0.04	-0.03	-1.08	-0.54	-1.04
Debt / Equity Ratio	-	0	0.08	0.05	0.04	0.09
Debt / EBITDA Ratio	-	-	5.05	0.95	1.35	2.77
Debt / FCF Ratio	-	-	-0.08	-0.02	-0.04	-0.05
Quick Ratio	11.20	5.99	5.41	1.13	2.30	1.49
Current Ratio	11.60	6.05	5.55	1.37	2.71	1.74
Earnings Yield	-45.74%	-160.43%	-89.82%	-97.37%	-88.24%	-59.57%
FCF Yield	-44.78%	-130.18%	-110.03%	-69.86%	-78.34%	-75.54%
Buyback Yield / Dilution	-	0.00%	0.00%	-42.55%	-87.43%	-80.38%
Total Shareholder Return	-	0.00%	0.00%	-42.55%	-87.43%	-80.38%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q